Clinical Trials Browser

Interventional × Cytomegalovirus Infections × Stem Cell Transplantation × Clear all

NCT05589844 2023-04-27

A Cytomegalovirus-Directed Vaccine (CMV-alphaDC1) for Preventing Cytomegalovirus Infection or Reactivation in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Phase 1 Withdrawn

Cytomegalovirus Infections